cyclopentanone has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, GZ; Fan, JH; Gao, XM; Gu, WW; Ishidoh, K; Nobuhiko, K; Sun, SC; Zhang, HL; Zhou, Q; Zhu, YM | 1 |
| Benmohamed, R; Benmohammed, R; Kirsch, DR; Silverman, RB; Trippier, PC | 1 |
2 other study(ies) available for cyclopentanone and Disease Models, Animal
| Article | Year |
|---|---|
Autophagy and cathepsin L are involved in the antinociceptive effect of DMBC in a mouse acetic acid-writhing model.
Topics: Acetic Acid; Analgesics; Animals; Autophagy; Benzylidene Compounds; Cathepsin L; Cyclopentanes; Disease Models, Animal; Epoxy Compounds; Female; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Pyridines; Signal Transduction | 2013 |
Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Cyclopentanes; Disease Models, Animal; Humans; Hydrogen Bonding; Mice; Mutation; PC12 Cells; Protein Folding; Pyrazolones; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |